EUDA Health Holdings annual r&d spending
2021
2022
2023
2024
2025
EUDA Health Holdings R&D Spending Growth & History (EUDA)
EUDA Health Holdings's r&d spending was $249 for fiscal 2025.
View full EUDA Health Holdings company overviewEUDA Health Holdings annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $249 | $249 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | −$17,209 | — |
| 2022 · Dec 31 | 2022-12-31 | $17,209 | −$112,056 | −86.69% |
| 2021 | 2021-12-31 | $129,265 | — | — |
EUDA Health Holdings quarterly r&d spending
Q1.22
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2022 · Mar 31 | 2022-03-31 | $2,946 | — | — |
EUDA Health Holdings r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, EUDA Health Holdings's r&d spending decreased from $129,265 to $249, a change of −$129,016. The latest reported quarter, Q1 2022 · Mar 31, shows $2,946.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review EUDA Health Holdings source filings ↗